Shop Online｜LA EXO｜MOMO
Company Profile
Development History
Management Team
What Is Exosome
Technical Advantages
GMP Laboratory & Facilities
International Certification
ExoGiov® Information
ExoGiov® Efficacy
shop online
AM Biotech warmly invites you to visit our booth and explore the latest developments and innovative applications of our targeted exosomes.
Our patented bio-pulsed exosomes (𝐄𝐱𝐨𝐠𝐢𝐨𝐯®) have demonstrated remarkable efficacy in hair growth and beauty, supported by multiple research studies and human clinical trials.
What you can experience at our booth:
✔ Hands-on experience with Exogiov® for beauty & hair growth
✔ Insights into cutting-edge exosome technologies and clinical applications
✔ Opportunities to build trusted CMO/CDMO partnerships
📅 November 11–13, 2025
📍 AsiaWorld-Expo｜𝗛𝗮𝗹𝗹 𝟴 – 𝗕𝗼𝗼𝘁𝗵 𝗘𝟬𝟳
📩 Visit us at 𝗛𝗮𝗹𝗹 𝟴 – 𝗕𝗼𝗼𝘁𝗵 𝗘𝟬𝟳 or email service@ambiotech.asia to start a collaboration!
更多文章read more
《Taiwan Business TOPICS》：From Anti-Aging to Biotech: Taiwan Looks to Take Its Exosomes Global
Source from:《Taiwan Business TOPICS》by Laurel Stewart The growing domestic medical aesthetics market has helped foster an increasingly sophisticated production ecosystem, creating opportunities in Taiwan and overseas. Ms. Chen began looking into cosmetic treatments for fine lines and sun-related redness a couple of years ago. Together with
AM Biotech Wins CBE Ingredient Innovation Award for ExoGiov® Bio-Pulsed Exosome Technology; Six Products Secure China Cosmetic Registrations, Advancing Global Expansion
Source from: 工商時報 李翊榛 AM Biotech’s proprietary ExoGiov® Bio-Pulsed Exosome Technology has been honored with the Ingredient Innovation Award at the 2026 China Beauty Expo (CBE). In addition to this prestigious recognition, six of the company’s skincare products have successfully obtained cosmetic regulatory approvals in mainland
AM Biotech Becomes Taiwan’s First Halal-Certified Exosome Company, Leveraging Proprietary Bio-Pulsed Technology to Tap into the US$100 Billion Global Halal Beauty Market
Source from: 經濟日報 AM Biotech, a Taiwan-based biotechnology innovator specializing in exosome technology, announced on March 2 that its proprietary exosome-based cosmetic ingredient has officially obtained Halal Certification, making the company the first exosome technology provider in Taiwan to achieve this milestone. Dr. Ju-Sheng Hsieh,
ExoGiov® Innovation: AM Biotech Accelerates European Expansion
ExoGiov®, a cosmetic raw material developed by AM Biotech, is registered under the international INCI name: "Chicken Embryonic Mesenchymal Cell-Derived Extracellular Vesicles."
AM Biotech Wins Prestigious National Innovation Award, Pioneering Bio-Pulsed Exosome Research
AM Biotech, a pioneering force in bio-pulsed exosome research, has been honored with the 21st National Innovation Award. This is a high commendation for AM Biotech’s long-standing dedication to research and innovation in the field of bio-pulsed exosomes.
AM Biotech Unveils Patented Bio-Pulsed Technology at Industry Forum
AM Bio Tech's "Patented Bio-Pulsed Technology Forum" held on December 15, 2024, successfully concluded. The event delved deep into the groundbreaking innovation behind Patented Bio-Pulsed Technology, shedding light on its mechanisms and providing compelling evidence of its effectiveness in skin rejuvenation and hair restoration. The
AM Biotech joins forces with PITDC to advance biotech innovation and expand into the trillion-dollar pharmaceutical market.
Ascension Medical Biotechnology (AM BioTech), a leading domestic company specializing in exosome functional induction technology and a pioneer in exosome applications for beauty and hair growth, announced on August 30, 2024, its partnership with Medical and Pharmaceutical Industry Technology and Development Center (PITDC) through a
Emerging Exosome Treatment Shines Hope on Chronic Kidney Disease and Renal Fibrosis
Chronic Kidney Disease (CKD) is increasingly recognized as a significant health concern worldwide. According to a recent report in The Lancet Regional Health, as of 2022, between 9.1% and 13.4% of the global population suffers from CKD.A promising avenue for treating CKD, particularly in reducing
AM Biotech Bio-Pulsed Exosomes entered the top 5 finalists pioneering innovation “Estée Lauder (NIV) BRKTHRU VOICES Prize” at 2024 in-Cosmetics Global
Ascension Medical Biotechnology Co. Ltd.” (AM BIOTECH) is a Taiwan medical biotechnology research company, producer of patented technology Bio-Pulsed Exosomes (Extracellular Vesicles), it is a Global Cross-Generation Innovative Cosmetic Ingredient recognized and favored by the international market in Europe and America.